Christopher Lindop
2010 - Haemonetics
In 2010, Christopher Lindop earned a total compensation of $987.3K as Chief Financial Officer Vice President of Business Development at Haemonetics, a 53% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,279 |
|---|---|
| Option Awards | $328,746 |
| Salary | $420,251 |
| Stock Awards | $71,755 |
| Other | $6,300 |
| Total | $987,332 |
Lindop received $420.3K in salary, accounting for 43% of the total pay in 2010.
Lindop also received $160.3K in non-equity incentive plan, $328.7K in option awards, $71.8K in stock awards and $6.3K in other compensation.
Rankings
In 2010, Christopher Lindop's compensation ranked 5,361st out of 10,439 executives tracked by ExecPay. In other words, Lindop earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,361 out of 10,439 | 49th |
Division Manufacturing | 1,933 out of 3,838 | 50th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 286 out of 667 | 57th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 134 out of 373 | 64th |
Industry Surgical and Medical Instruments and Apparatus | 71 out of 240 | 70th |
Source: SEC filing on June 17, 2010.
Lindop's colleagues
We found five more compensation records of executives who worked with Christopher Lindop at Haemonetics in 2010.